|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08247 BIOSINO BIO-TEC
Nominal 
0.860 0.000 (0.000%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 95,815 | -28.404% | 263,069 | 289,073 | 373,071 | 348,225 |
| Cost of Sales | (58,437) | -22.391% | (154,669) | (161,708) | (226,794) | (204,633) |
| Gross Profit | 37,378 | -36.140% | 108,400 | 127,365 | 146,277 | 143,592 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (19,502) | (1,303) | (194) | (129) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 60 | -- | (416) | 12,346 | 6,534 | 1,573 | |
| Profit / (Loss) before Taxation | (22,693) | 40.557% | (59,720) | (17,613) | 18,516 | 6,407 | |
| Taxation | (209) | -90.364% | 2,831 | (1,628) | (4,314) | (3,247) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 4,926 | -4.014% | 14,357 | 7,593 | (6,096) | (4,300) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (17,976) | 36.368% | (42,532) | (11,648) | 8,106 | (1,140) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 4,438 | 5.919% | 7,639 | 6,072 | 6,482 | 10,346 |
| Depreciation & Amortisation | 10,254 | -8.593% | 17,808 | 20,357 | 24,329 | 27,928 |
| Directors' Emoluments | -- | -- | 3,131 | 3,819 | 2,122 | 2,522 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -12.400 | 36.264% | -29.400 | -8.000 | 5.600 | -0.800 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.164 | (0.045) | 0.308 | 0.338 |
| NBV per share ($) | 1.036 | -- | 1.160 | 1.454 | 1.423 | 1.217 |
| Remarks: | Real time quote last updated: 30/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -17,976 |
| %Change | 36.368% |
| EPS / (LPS) | RMB -0.124 |
| NBV Per Share (¥) | RMB 1.036 |